News

Niowave, Inc. and Ratio Therapeutics Sign Supply Agreement for Actinium-225 to Advance Targeted Alpha Therapies

View more

Jun 18, 2026

IBA launches Cyclone® iKure, a cyclotron designed for industrial scale Astatine-211 production

View more

Jun 03, 2026

Curium Announces a Strategic Investment of Over €32 million in Saclay, France

View more

Jun 03, 2026

ASCO: Lu-177 edotreotide yields sustained quality-of-life gains

View more

Jun 03, 2026

ITM Announces Phase 3 COMPETE Data Supporting Single-Timepoint Dosimetry for n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at SNMMI 2026

View more

Jun 03, 2026

IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

View more

May 22, 2026